Article
Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting.
Clinica chimica acta; international journal of clinical chemistry - 1 Nov 2016
Matsumoto Nariyoshi, Mori Sayaka, Hasegawa Hiroo, Sasaki Daisuke, Mori Hayato, Tsuruda Kazuto, Imanishi Daisuke, Imaizumi Yoshitaka, Hata Tomoko, Kaku Norihito, Kosai Kousuke, Uno Naoki, Miyazaki Yasushi, Yanagihara Katsunori
Abstract excerpt
INTRODUCTION: Recently, novel calreticulin (CALR) mutations were discovered in Janus kinase 2 (JAK2) non-mutated myelofibrosis (PMF) and essential thrombocythemia (ET) cases, with a frequency of 60-80%. We examined clinical correlations and CALR mutation frequency in our myeloproliferative neoplasms (MPN) cases, and introduce an effective test method for use in clinical practice. METHODS: We examined 177 samples...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
